KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Income from Continuing Operations (2017 - 2026)

Elanco Animal Health's Income from Continuing Operations history spans 9 years, with the latest figure at 276000000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 3350.0% to 276000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 232000000.0, a 168.64% decrease, with the full-year FY2025 number at 232000000.0, down 168.64% from a year prior.
  • Income from Continuing Operations hit 276000000.0 in Q4 2025 for Elanco Animal Health, down from 34000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for ELAN hit a ceiling of 364000000.0 in Q3 2024 and a floor of 1096000000.0 in Q3 2023.
  • Historically, Income from Continuing Operations has averaged 84300000.0 across 5 years, with a median of 52000000.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 179.69% in 2022 and later crashed 3350.0% in 2025.
  • Tracing ELAN's Income from Continuing Operations over 5 years: stood at 105000000.0 in 2021, then skyrocketed by 48.57% to 54000000.0 in 2022, then plummeted by 161.11% to 141000000.0 in 2023, then surged by 94.33% to 8000000.0 in 2024, then crashed by 3350.0% to 276000000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ELAN at 276000000.0 in Q4 2025, 34000000.0 in Q3 2025, and 11000000.0 in Q2 2025.